Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Risk factors associated with pulmonary tuberculosis: smoking, diabetes and anti-TNFα drugs.

Ferrara G, Murray M, Winthrop K, Centis R, Sotgiu G, Migliori GB, Maeurer M, Zumla A.

Curr Opin Pulm Med. 2012 May;18(3):233-40. doi: 10.1097/MCP.0b013e328351f9d6. Review.

PMID:
22388583
2.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
3.

[Screening for tuberculosis infection prior to medical therapy].

Ravn P.

Ugeskr Laeger. 2011 Mar 21;173(12):893-6. Danish.

PMID:
21419060
4.

Infectious complications of tumor necrosis factor blockade.

Wallis RS.

Curr Opin Infect Dis. 2009 Aug;22(4):403-9. doi: 10.1097/QCO.0b013e32832dda55. Review.

PMID:
19491672
5.

Infectious complications with anti-TNFalpha therapy in rheumatic diseases: a review.

Toussirot E, Streit G, Wendling D.

Recent Pat Inflamm Allergy Drug Discov. 2007 Feb;1(1):39-47. Review.

PMID:
19075965
6.

[Frontier of mycobacterium research--host vs. mycobacterium].

Okada M, Shirakawa T.

Kekkaku. 2005 Sep;80(9):613-29. Japanese.

PMID:
16245793
7.

[Tuberculosis, anti-TNF agents and other immunosuppressants: evolution of preventitive strategies].

Lioté H.

Rev Mal Respir. 2008 Dec;25(10):1237-49. Review. French.

PMID:
19107015
8.

[Recent progress in mycobacteriology].

Okada M, Kobayashi K.

Kekkaku. 2007 Oct;82(10):783-99. Japanese.

PMID:
18018602
9.

[Tuberculosis in compromised hosts].

[No authors listed]

Kekkaku. 2003 Nov;78(11):717-22. Japanese.

PMID:
14672050
10.

Risk of tuberculosis from exposure to tobacco smoke: a systematic review and meta-analysis.

Bates MN, Khalakdina A, Pai M, Chang L, Lessa F, Smith KR.

Arch Intern Med. 2007 Feb 26;167(4):335-42. Review.

PMID:
17325294
11.

[Preventive measures against tuberculosis in working facilities and companies].

Suzuki K, Satou K.

Kekkaku. 2007 Mar;82(3):201-16. Japanese.

PMID:
17444125
12.

Tuberculosis and noncommunicable diseases: neglected links and missed opportunities.

Creswell J, Raviglione M, Ottmani S, Migliori GB, Uplekar M, Blanc L, Sotgiu G, Lönnroth K.

Eur Respir J. 2011 May;37(5):1269-82. doi: 10.1183/09031936.00084310. Epub 2010 Oct 14. Review.

13.
14.

Associations between tobacco and tuberculosis.

Chiang CY, Slama K, Enarson DA.

Int J Tuberc Lung Dis. 2007 Mar;11(3):258-62. Review. Erratum in: Int J Tuberc Lung Dis. 2007 Aug;11(8):936.

PMID:
17352089
15.
16.

Pulmonary infectious complications of tumor necrosis factor blockade.

Wallis RS, Schluger NW.

Infect Dis Clin North Am. 2010 Sep;24(3):681-92. doi: 10.1016/j.idc.2010.04.010. Review.

PMID:
20674798
17.

Comparison of screening procedures for Mycobacterium tuberculosis infection among patients with inflammatory diseases.

Soborg B, Ruhwald M, Hetland ML, Jacobsen S, Andersen AB, Milman N, Thomsen VO, Jensen DV, Koch A, Wohlfahrt J, Ravn P.

J Rheumatol. 2009 Sep;36(9):1876-84. doi: 10.3899/jrheum.081292. Epub 2009 Jul 31.

PMID:
19648300
18.

[Prospects for development of new antituberculous drugs].

Tomioka H.

Kekkaku. 2002 Aug;77(8):573-84. Japanese.

PMID:
12235850
19.

[Tuberculosis and anti-TNFalpha therapy].

Popović-Grle S.

Reumatizam. 2007;54(2):54-7. Croatian.

PMID:
18351140
20.

Recommendations for the diagnosis and treatment of latent and active tuberculosis in inflammatory joint diseases for candidates for therapy with tumor necrosis factor alpha inhibitors--March 2008 update.

Eurico Fonseca J, Lucas H, Canhão H, Duarte R, José Santos M, Villar M, Faustino A, Raymundo E; Rheumatoid Arthritis Study Group of Portuguese Society of Rheumatology.

Rev Port Pneumol. 2008 Mar-Apr;14(2):271-83.

PMID:
18564448

Supplemental Content

Support Center